The orthobiologics market is estimated to be valued at US$ 6,515.2 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Orthobiologics products are used to aid in the regeneration of injured or damaged bones and tissues. They include bone grafts, bone graft substitutes, stem cells, cell-based matrices, and growth factors & cytokines. ... Read more

Orthobiologics includes products made from natural or synthetic materials used in orthopedic surgeries to repair musculoskeletal injuries and disorders. Orthobiologics products such as bone graft substitutes, viscosupplementation, stem cell therapies and platelet rich plasma injections are used for bone fractures, spinal fusion, joint repair, and soft tissue injuries. These products aid faster healing, reduce pain and risk of infection. The global ... Read more